Gattini D, Murphy A, Belza C, Avitzur Y, Wales P W
Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada; Division of Gastroenterology, Hepatology & Nutrition, Hospital for Sick Children, Toronto, Ontario, Canada; Group for Improvement of Intestinal Function and Treatment (GIFT), Transplant Centre, Toronto, Ontario, Canada.
Division of Geriatric Medicine, Massachusetts General Hospital, Boston, MA, USA.
Clin Nutr. 2025 Feb;45:75-80. doi: 10.1016/j.clnu.2024.12.014. Epub 2024 Dec 13.
BACKGROUND & AIMS: Central line-associated bloodstream infections (CLABSI) represent one of the most common and serious complications in children with intestinal failure (IF). This study aimed to assess if there is an association between the use of enteral devices (feeding tubes and stomas) with rate of CLABSI after adjusting for clinically relevant factors. Second, association between enteral devices with time to first CLABSI event was evaluated.
Retrospective cohort of 202 children with IF and home parenteral nutrition treated at The Hospital for Sick Children between January 2006, and December 2017, with a minimum of 12 months of follow-up. Negative binomial multivariable regression model was used to assess factors associated with rate of CLABSI. Cox proportional hazard regression model was used to assess factors associated with time to first CLABSI event.
The use of feeding tubes [RR 1.10 (95%CI 0.88-1.37); p = 0.407] or stomas [RR 1.00 (95%CI 0.82-1.22); p = 0.974] was not associated with rate of CLABSI after adjusting for confounding factors. There was a significant association between history of prematurity [RR 1.36 (95%CI 1.09-1.70); p = 0.007], male sex [RR 1.28 (95%CI 1.05-1.56); p = 0.016], age at diagnosis of intestinal failure <1 year [RR 2.41 (95%CI 1.75-3.33); p < 0.001], having <50 % of small bowel length expected for age [RR 2.39 (95%CI 1.87-3.05); P < 0.001], and small bowel bacterial overgrowth (SBBO) [RR 1.38 (95%CI 1.10-1.74); p = 0.006], with rate of CLABSI events after multivariable analysis. The use of feeding tubes [HR 0.79 (95%CI 0.49-1.26); p = 0.315] or stomas [HR 1.25 (95%CI 0.81-1.94); p = 0.308] was not associated with time to first CLASBSI episode after multivariable regression analysis. Only length of small bowel <50 % was associated with time to first CLABSI event on multivariable analysis [HR 1.83 (95%CI 1.14-2.93); p = 0.012].
Feeding tubes and stomas were not associated with increased rate of CLABSI or time to first CLABSI episode. However, prematurity, male sex, age at diagnosis of intestinal failure <1 year, having <50 % of small bowel length expected for age, and SBBO were associated with rate of CLABSI events; and having <50 % of small bowel length was associated with time to first CLABSI event. Prospective, multicenter studies accounting for care delivery and prevention bundles are needed to identify patients that would benefit from additional interventions to prevent CLABSI.
中心静脉导管相关血流感染(CLABSI)是肠衰竭(IF)患儿最常见且最严重的并发症之一。本研究旨在评估在调整临床相关因素后,肠内装置(喂养管和造口)的使用与CLABSI发生率之间是否存在关联。其次,评估肠内装置与首次发生CLABSI事件的时间之间的关联。
对2006年1月至2017年12月在病童医院接受治疗且接受家庭肠外营养的202例IF患儿进行回顾性队列研究,随访时间至少12个月。采用负二项式多变量回归模型评估与CLABSI发生率相关的因素。采用Cox比例风险回归模型评估与首次发生CLABSI事件的时间相关的因素。
在调整混杂因素后,使用喂养管[相对风险(RR)1.10(95%置信区间[CI]0.88 - 1.37);p = 0.407]或造口[RR 1.00(95%CI 0.82 - 1.22);p = 0.974]与CLABSI发生率无关。多变量分析后,早产史[RR 1.36(95%CI 1.09 - 1.70);p = 0.007]、男性[RR 1.28(95%CI 1.05 - 1.56);p = 0.016]、肠衰竭诊断时年龄<1岁[RR 2.41(95%CI 1.75 - 3.33);p < 0.001]、小肠长度小于预期年龄的50%[RR 2.39(95%CI 1.87 - 3.05);P < 0.001]以及小肠细菌过度生长(SBBO)[RR 1.38(95%CI 1.10 - 1.74);p = 0.006]与CLABSI事件发生率相关。多变量回归分析后,使用喂养管[风险比(HR)0.79(95%CI 0.49 - 1.26);p = 0.315]或造口[HR 1.25(95%CI 0.81 - 1.94);p = 0.308]与首次发生CLASBSI事件的时间无关。多变量分析中,只有小肠长度小于50%与首次发生CLABSI事件的时间相关[HR 1.83(95%CI 1.14 - 2.93);p = 0.012]。
喂养管和造口与CLABSI发生率增加或首次发生CLABSI事件的时间无关。然而,早产、男性、肠衰竭诊断时年龄<1岁、小肠长度小于预期年龄的50%以及SBBO与CLABSI事件发生率相关;小肠长度小于50%与首次发生CLABSI事件的时间相关。需要开展前瞻性、多中心研究以考虑护理提供和预防措施组合,从而确定可能从额外干预措施中受益以预防CLABSI的患者。